Trial reportEuropean journal of nutrition2025
Assessment of the effect of routine-dose vitamin D3 supplementation in Chinese women of childbearing age with vitamin D insufficiency.
Trial report in European journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serum 25-Hydroxyvitamin D3 Status in Adolescents With Anxiety Disorders: A Case-Control and Vitamin D Supplementation Substudy.Brain and behavior · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundIt was reported that vitamin D deficiency is common in Chinese women of childbearing age. Although most government dietary guidelines recommend routine-dose (400-800 IU/d), the evidence from intervention studies using routine-dose is quite limited.
objectiveIn this study, the effects of daily supplementation with routine-dose of vitamin D3 in women of childbearing age with vitamin D insufficiency on vitamin D nutritional status and bone metabolism markers were assessed by dynamic tracking, and the thresholds for appropriate levels of vitamin D in this population was also explored.
methodsSingle-group repeated measures design was performed. Forty-five women of childbearing age (18-50 years) with vitamin D insufficiency [serum total 25(OH)D < 20 ng/mL] were recruited. A 26-week trial of oral vitamin D3 supplementation at 400 international units (IU)/day (n = 15) and 800 IU/day (n = 25) was conducted for subjects in the intervention group with a parallel observation group (n = 5). Trends in serum total 25(OH)D and parathyroid hormone (PTH) were observed at baseline, 2, 3, 4, 5, 6, 10, 12, 14, 16, and 26 weeks, while free and bioavailable 25(OH)D and bone turnover markers (BTMs) were dynamically tracked. The intervention effect was then further analyzed by subgroup including 400 IU/d + low PTH group (n = 7), 400 IU/d + high PTH group (n = 8), 800 IU/d + low PTH group (n = 12), and 800 IU/d + high PTH group (n = 13) based on baseline serum PTH concentration. The appropriate level of total 25(OH)D was defined as the thresholds at which serum PTH can be maximally suppressed or plateaued and was explored by polynomial comparison and Gaussian process regression.
resultsA total of 44 out of 45 (97.8%) participants completed the intervention and follow-up. By dynamic tracking, serum total 25(OH)D increased rapidly in women of childbearing age with vitamin D insufficiency after supplementation both with 400 IU/d and 800 IU/d of vitamin D3 during the first 4 weeks. Serum vitamin D status improved greatly after 26 weeks, with significant increases in total 25(OH)D, free 25(OH)D and bioavailable 25(OH)D concentrations compared with baseline. There was no statistically significant difference in the effect of the intervention between the two dose groups. Serum PTH decreased during the first 6 weeks, after which it entered a plateau, especially in the group with higher baseline serum PTH. While BTMs were relatively stable. The range of thresholds obtained by polynomial comparison and Gaussian process regression were 20.24-23.95 ng/mL and 20.2-21.65 ng/mL, respectively.
conclusionRoutine-dose of vitamin D3 supplementation was proved to be, an effective and compliant supplementation approach in women of childbearing age with vitamin D insufficiency. The average of the total 25(OH)D threshold predicted by Gaussian process regression for the high PTH groups was approximately 21 ng/mL, which could be recommended as the reference level for appropriate vitamin D in Chinese women of childbearing age. This trial was registered with the Chinese clinical trial registry as ChiCTR2200058290. CLINICAL
trial registrationChiCTR2200058290. https://www.chictr.org.cn/showprojEN.html?proj=162610.
Indexed as
Identifiers
40445221What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.